Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Featured News

    Henry Eigelsbach, Microbiologist Known for Tularemia Research, Dies at 100

    By Global Biodefense StaffDecember 17, 2019
    In Memoriam Henry Eigelsbach Fort Detrick
    Share
    Facebook LinkedIn Reddit Email

    Renowned microbiologist Henry “Hank” Eigelsbach died of natural causes on December 6, 2019 at the age of 100.

    The former Fort Detrick scientist is best known for his research on Francisella tularensis, the causative agent of tularemia. Eigelsbach was stationed at ‘Camp Detrick’ during World War II while in the Navy, and remained working there for decades as a microbiologist after leaving active duty.

    Read more by Heather Mongilio at Frederick News Post

    Renowned Fort Detrick Microbiologist, Infectious Disease Researcher, Educator

    Dr. Eigelsbach was the author of more than 50 papers published in recognized research journals, and 7 book chapters, including in Bergey’s Manual of Systematic Bacteriology and The Manual of Clinical Microbiology. He also delivered dozens of presentations at national professional meetings that established him as an international authority on tularemia, the field in which his research concentrated. He was a Charter Fellow of the American Academy of Microbiology, and Diplomat of the American Board of Microbiology. He was the Frederick, Maryland Branch president of the Scientific Research Society of America.

    His contribution to tularemia vaccines, which began at the outset of his scientific career and remained a lifelong passion, is recognized around the world. Dr. Eigelsbach is acknowledged as a global ambassador for science, and as a pathfinder in medical research focused on the protection of humans from infectious diseases.”

    Dr. Stephen Prior, former president of DynPort, LLC

    Following his retirement as medical microbiologist at Fort Detrick, he served as consultant for the national drug company Aries, the Salk Institute, and DynPort. His work with DynPort led to the advanced development and large-scale production of tularemia vaccine.

    Read more at Tribute Archive

    Army Research & Development Newsmagazine – June 1962

    June 1962 Article featuring Dr. Henry T. Eigelsbach

    Tularemia Research – Select Papers

    Please find below a collection of full-access research papers co-authored by Dr. Eigelsbach.

    Hornick RB, Eigelsbach HT. Aerogenic immunization of man with live Tularemia vaccine. Bacteriol Rev. 1966;30(3):532–538.

    Schricker RL, Eigelsbach HT, Mitten JQ, Hall WC. Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425. Infect Immun. 1972;5(5):734–744.

    Tulis JJ, Eigelsbach HT, Kerpsack RW. Host-parasite relationship in monkeys administered live tularemia vaccine. Am J Pathol. 1970;58(2):329–336.

    Andron LA II, Eigelsbach HT. Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis. Infect Immun. 1975;12(1):137–142.

    McGavran MH, White JD, Eigelsbach HT, Kerpsack RW. Morphologic and Immunohistochemical Studies of the Pathogenesis of Infection and Antibody Formation Subsequent to Vaccination of Macaca irus with an Attenuated Strain of Pasteurella tularensis: I. Intracutaneous Vaccination. Am J Pathol. 1962;41(3):259–271.

    Eigelsbach HT, Chambers LA, Coriell LL. Electron Microscopy of Bacterium tularense. J Bacteriol. 1946;52(2):179–185.

    Edited by S. Lizotte

    In Memoriam
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleKey Lawmaker Calls for Halt to BioDetection 21 Program
    Next Article Getting to Zero Ebola Cases: Better Communication to Overcome Community Mistrust

    Related Stories

    How Putin Borrowed a Page From Assad’s Chemical Weapon Playbook

    September 11, 2020

    PBS Filmmaker Q&A on Covering Ebola Response in North Kivu

    December 23, 2019

    2nd Case of Possible Remission of HIV-1 Reported in London

    March 19, 2019

    Non-Medical Obstacles Impacting Public Health Responses

    March 18, 2019
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.